Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Tatva Chintan Pharma Chem Ltd.

Jul 21, 01:31 BSE 1714.00 ( -0.10 -0.01%)

Volume82779

Prev. Close
1714.10

Open Price
1742.45

Today's Low / High

1678.55 1786.70

Bid. Price (Qty.)1707.10 (42)

Offer Price (Qty.)
1711.10 (69)

52 Wk Low / High

977.85 1714.10

Jul 21, 01:19 NSE 1717.00(+ 3.30 0.19%)

Volume1334778

Prev. Close
1713.70

Open Price
1760.00

Today's Low / High

1674.00 1785.00

Bid Price (Qty.)1717.00 (77)

Offer Price (Qty.) 1718.00 (9)

52 Wk Low / High

976.40 1713.70

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	233.92	233.92	233.92	221.65	221.65

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.39	23.39	23.39	22.17	22.17
Total Share Capital	23.39	23.39	23.39	22.17	22.17

Reserves and Surplus	758.37	715.43	713.69	492.63	450.92
Total Reserves and Surplus	758.37	715.43	713.69	492.63	450.92
Total Shareholders Funds	781.76	738.82	737.08	514.79	473.09

NON-CURRENT LIABILITIES
Long Term Borrowings	5.01	0.00	0.64	4.23	13.11
Other Long Term Liabilities	1.20	0.00	0.00	0.00	0.02
Long Term Provisions	2.59	1.40	1.33	1.15	0.65
Total Non-Current Liabilities	8.80	1.40	1.97	5.38	13.78

CURRENT LIABILITIES
Short Term Borrowings	115.36	36.39	13.63	166.03	106.83
Trade Payables	58.25	32.69	45.03	32.19	44.51
Other Current Liabilities	38.97	26.53	20.64	37.59	19.91
Short Term Provisions	0.56	0.42	0.36	0.33	0.18
Total Current Liabilities	213.14	96.03	79.66	236.13	171.43

Total Capital And Liabilities	1003.69	836.25	818.72	756.30	658.30

ASSETS
NON-CURRENT ASSETS
Tangible Assets	605.72	525.55	426.54	195.77	159.30
Intangible Assets	5.26	3.12	0.35	0.48	0.32
Capital Work-In-Progress	23.35	21.54	72.93	230.74	51.49
Intangible Assets Under Development	0.00	2.78	3.61	0.00	0.00
Fixed Assets	634.32	552.99	503.42	426.99	211.10
Non-Current Investments	4.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	9.57	12.62	12.30	12.36	8.71
Other Non-Current Assets	6.29	5.39	5.09	3.40	2.60
Total Non-Current Assets	654.18	571.00	520.81	442.75	222.42


CURRENT ASSETS
Current Investments	0.00	0.00	10.05	0.00	0.00
Inventories	196.07	133.95	152.77	162.50	169.96
Trade Receivables	119.03	82.53	69.85	84.40	56.60
Cash And Cash Equivalents	8.79	14.10	38.29	44.76	176.99
Short Term Loans And Advances	0.27	0.24	0.24	0.17	0.16
OtherCurrentAssets	25.35	34.43	26.70	21.72	32.18
Total Current Assets	349.51	265.25	297.91	313.56	435.89

Total Assets	1003.69	836.25	818.72	756.30	658.30

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	17.17	34.66	19.19	80.05

BONUS DETAILS
Bonus Equity Share Capital	0.00	12.05	12.05	12.05	12.05

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00
No. of Equity Shares (in Lacs)	233.92

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.39
Total Share Capital	23.39
Reserves and Surplus	758.37
Total Reserves and Surplus	758.37
Total Shareholders Funds	781.76
NON-CURRENT LIABILITIES
Long Term Borrowings	5.01
Other Long Term Liabilities	1.20
Long Term Provisions	2.59
Total Non-Current Liabilities	8.80
CURRENT LIABILITIES
Short Term Borrowings	115.36
Trade Payables	58.25
Other Current Liabilities	38.97
Short Term Provisions	0.56
Total Current Liabilities	213.14
Total Capital And Liabilities	1003.69
ASSETS
NON-CURRENT ASSETS
Tangible Assets	605.72
Intangible Assets	5.26
Capital Work-In-Progress	23.35
Intangible Assets Under Development	0.00
Fixed Assets	634.32
Non-Current Investments	4.00
Deferred Tax Assets [Net]	9.57
Other Non-Current Assets	6.29
Total Non-Current Assets	654.18
CURRENT ASSETS
Current Investments	0.00
Inventories	196.07
Trade Receivables	119.03
Cash And Cash Equivalents	8.79
Short Term Loans And Advances	0.27
OtherCurrentAssets	25.35
Total Current Assets	349.51
Total Assets	1003.69
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00
BONUS DETAILS
Bonus Equity Share Capital	0.00